Inventor · disambiguated record
Kelvin Hin-Yeong Yong
Also filed as: YONG KELVIN · YONG KELVIN H · YONG KELVIN HIN-YEONG
10 granted patents·8 pending applications·20 citations·filing 2007–2022
84Inventor score
Top patents by PatentIndex Score
18 records- 0193US10894796B2MK2 inhibitors, synthesis thereof, and intermediates theretoCELGENE CAR LLC·Filed 2018·Granted Jan 19, 2021·8 cites·19 claims
- 0287US9120818B2Process and intermediates for preparing macrolactamsCHEN CHENG·Filed 2011·Granted Sep 1, 2015·8 cites·20 claims
- 0385US11655257B2MK2 inhibitors, synthesis thereof, and intermediates theretoCELGENE CAR LLC·Filed 2021·Granted May 23, 2023·1 cites·10 claims
- 0476US7687631B2Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonateSCHERING CORP·Filed 2007·Granted Mar 30, 2010·2 cites·10 claims
- 0571US10517873B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2019·Granted Dec 31, 2019·0 cites·3 claims
- 0670US10005760B2Forms and compositions of an ERK inhibitorCELGENE CAR LLC·Filed 2015·Granted Jun 26, 2018·1 cites·21 claims
- 0766US2023128975A1Process for the preparation of bromodomain inhibitorCELGENE QUANTICEL RES INC·Filed 2022·Application pending·0 cites
- 0863US2017066715A1Amidation processMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 0960US2016075645A1Amidation processMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 1059US10202364B2Forms and compositions of an ERK inhibitorCELGENE CAR LLC·Filed 2018·Granted Feb 12, 2019·0 cites·16 claims
- 1159US2013331597A1Amidation processHUMPHREY GUY·Filed 2012·Application pending·0 cites
- 1256US11566004B2Process for the preparation of bromodomain inhibitorCELGENE QUANTICEL RES INC·Filed 2019·Granted Jan 31, 2023·0 cites·17 claims
- 1349US2024246990A1Process of preparing (1r, 4r, 5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-en-1-yl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione(salinosporamide a; marizomib)CELGENE INT II SARL·Filed 2020·Application pending·0 cites
- 1449US2011124867A1Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist ActivitySCHERING CORP·Filed 2008·Application pending·0 cites
- 1547US2024228475A1Processes for the preparation of (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dioneCELGENE CORP·Filed 2022·Application pending·0 cites
- 1643US7985860B2Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivativesSCHERING CORP·Filed 2007·Granted Jul 26, 2011·0 cites·12 claims
- 1740US2010324295A1Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereofSCHERING CORP·Filed 2008·Application pending·0 cites
- 1837US8329905B2Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonateYONG KELVIN H·Filed 2010·Granted Dec 11, 2012·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Kelvin Hin-Yeong Yong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →